Neuro-Innovators, Inc.

Neuro-Innovators, Inc. Healing Brains with Neuroplastic Medicine™ Neuro-Innovators (NIV) is a clinical-stage, first-in-class drug company developing next-generation neurotherapeutics designed to enhance neuroplasticity—the brain’s remarkable ability to rewire, rebuild, and recover after injury or disease. Challenge: Conventional neurotherapeutics—single-molecule drugs—have consistently underperformed in treating brain disorders. They are slow and costly to develop; risk failing safety and efficacy hurdles; and address limited mechanisms of action poorly suited for complex, networked neurological systems. Solution: De-risked Polypharmacology Strategy: Engineer Polypharmacological Treatments: 1) Combine FDA-approved drugs into a single oral capsule that acts on multiple neuroplasticity mechanisms simultaneously; and 2) Leverage FDA’s 505(b)(2) pathway. Target Neurologic Conditions with Measurable Objective Outcomes. Lead indication, aid in lowering chronic stroke motor disability is linked to an FDA-accepted, objective functional outcome metrics, further reducing approval risks. Lead Program: NIV-001 has the potential to redefine treatment for the 7 million U.S. stroke survivors with chronic motor disabilities, driving a paradigm shift in neuro-recovery medicine. This segment alone represents a $20+ billion unmet need. Importantly, our platform can be tailored for diverse neurodegenerative / neurologic conditions, ranging from: Dementia, cognitive decline, Movement disorders (e.g., Parkinson’s), Traumatic Brain Injury (TBI). Come help us or let us know if you would like to learn more. h.schroeder@neuro-innovators.com